Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP651348.RAgf56uxrrJ8nSyoJn-eBbvWPn6bDOEVg38jvm1UnkTEs130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP651348.RAgf56uxrrJ8nSyoJn-eBbvWPn6bDOEVg38jvm1UnkTEs130_assertion type Assertion NP651348.RAgf56uxrrJ8nSyoJn-eBbvWPn6bDOEVg38jvm1UnkTEs130_head.
- NP651348.RAgf56uxrrJ8nSyoJn-eBbvWPn6bDOEVg38jvm1UnkTEs130_assertion description "[Studying these extremely rare events of tumour reversion and deciphering these pathways, which involve SIAH1, presenilin 1, TSAP6 and translationally controlled tumour protein (TCTP), could lead to new avenues in cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP651348.RAgf56uxrrJ8nSyoJn-eBbvWPn6bDOEVg38jvm1UnkTEs130_provenance.
- NP651348.RAgf56uxrrJ8nSyoJn-eBbvWPn6bDOEVg38jvm1UnkTEs130_assertion evidence source_evidence_literature NP651348.RAgf56uxrrJ8nSyoJn-eBbvWPn6bDOEVg38jvm1UnkTEs130_provenance.
- NP651348.RAgf56uxrrJ8nSyoJn-eBbvWPn6bDOEVg38jvm1UnkTEs130_assertion SIO_000772 19180095 NP651348.RAgf56uxrrJ8nSyoJn-eBbvWPn6bDOEVg38jvm1UnkTEs130_provenance.
- NP651348.RAgf56uxrrJ8nSyoJn-eBbvWPn6bDOEVg38jvm1UnkTEs130_assertion wasDerivedFrom befree-20140225 NP651348.RAgf56uxrrJ8nSyoJn-eBbvWPn6bDOEVg38jvm1UnkTEs130_provenance.
- NP651348.RAgf56uxrrJ8nSyoJn-eBbvWPn6bDOEVg38jvm1UnkTEs130_assertion wasGeneratedBy ECO_0000203 NP651348.RAgf56uxrrJ8nSyoJn-eBbvWPn6bDOEVg38jvm1UnkTEs130_provenance.